SORTAC
Live / Registered — Registered (as of 30 Jan 2024)
What this means for you
Registered since 30 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79349852
- Registration number
- 7292341
- Mark type
- Stylized text
- Filed
- 22 Jun 2022
- Published for opposition
- 14 Nov 2023
- Registered
- 30 Jan 2024
- Attorney of record
- JENNIFER A. VAN KIRK
Goods and services
- Class 005 — Pharmaceuticals: Biochemical preparations for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; chemical preparations for medical purposes neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; biological preparations for medical purposes for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; chemical reagents for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; medical preparations in the form of tablets, capsules, solutions, powders for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; protein synthesis inhibitors being chemical substances and compounds for medical use for the treatment of neurological diseases, inflammatory diseases, metabolic diseases, cancer, cardiovascular and vascular diseases, genetic diseases, kidney diseases, protein aggregation disorders, autoimmune diseases; diagnostic preparations and materials namely medical strips
- Class 010 — Medical apparatus: Medical apparatus and instruments, namely inhalers, pumps, dispensers; Medical instruments, namely inhalers, pumps, dispensers; diagnostic, examination and monitoring equipment for medical purposes, namely medical strips; all of the aforementioned goods not relating to the field of vascular and/or cardiovascular diseases
Owner
- Draupnir Bio ApS, DK
- Draupnir Bio ApS, DK
- Draupnir Bio ApS, DK
- Draupnir Bio ApS, DK
Prosecution history
- 21 May 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 May 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 May 2024 — FINAL DISPOSITION PROCESSED
- 30 Apr 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 30 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Nov 2023 — PUBLISHED FOR OPPOSITION
- 13 Nov 2023 — NOTIFICATION PROCESSED BY IB
- 25 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 25 Oct 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 25 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Oct 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Oct 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE